Email this article DRUG-DRUG INTERACTIONS IIKE A REASON OF ADVERSE DRUG REACTIONS
- Issue: Vol 21, No 3 (2013)
- Pages: 70-76
- Section: Articles
- URL: https://journal-vniispk.ru/pavlovj/article/view/4767
- DOI: https://doi.org/10.17816/PAVLOVJ2013370-76
- ID: 4767
Cite item
Full Text
Abstract
Drug-drug interactions are a serious public health problem because they are cause of adverse drug reactions and one of the reasons for hospitalization of patients. Many patient’s admissions associated with drug-drug interactions could be avoided by proper medical supervision over the condition of patients or by using of alternative drugs. The analysis of spontaneous reports was used for assessment of adverse drug reactions caused by drug-drug interactions and defined the scope of the problem in Russia.
Full Text
##article.viewOnOriginalSite##References
- Разработка методов изучения и профилактики осложнений фармакотерапии: учебное пособие / В.К. Лепахин [и др.]. – М.: РУДН, 2008. – 225 с.
- Сюбаев Р.Д. Принципы доклинической оценки риска токсикологического взаимодействия лекарственных средств и критерии безопасности комбинированной фармакотерапии: автореф. дис. … д-ра мед. наук / Р.Д. Сюбаев. – М., 2012. – 24 с.
- Осложнения фармакотерапии. Лекарственное взаимодействие / С.Б. Фитилев [и др.]. – М.: ООО "Петроруш"2011. – 56 с.
- Angelin B. Quinidine reduces biliary clearance of digoxin in man / B. Angelin, A. Arvidsson, R. Dahlqvist // EurJ Clin Invest. – 1987. – №17. – Р. 262-265.
- Baldwin S.J. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9 / S.J. Baldwin, J.C. Bloomer, G.J. Smith // Xenobiotica. – 1995. – №25. – Р. 261-270.
- Bergendal L. Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden./ L. Bergendal, A. Friberg, A.M. Schaffrath // Pharm World Sci. – 1995. – №17. – Р. 152-157.
- Bjorkman I.K. Drug-drug interactions in the elderly / I.K. Bjorkman, J. Fastbom, I.K. Schmidt // Ann Pharmacother. – 2002. – № 36(11). – Р. 1675-1681.
- Burns J.J. Enzyme stimulation and inhibition in the metabolism of drugs / J.J. Burns, A.H. Conney // Proceedings of the Royal Society of Medicine. – 1965. – №58. – Р. 955-960.
- Christensen L.K. Sulphaphenazoleinduced hypoglycaemic attacks in tolbutamide-treated diabetics / L.K. Christensen, J.M. Hansen, M. Kristens // Lancet. – 1963. – №2. – Р. 298-301.
- Cruciol-Souza J.M. A pharmaco epidemiologic study of drug interactions in a Brazilian teaching hospital / J.M. Cruciol-Souza, J.C. Thomson // Clinics. – 2006. – №61(6). – Р. 515-520.
- Delafuente J.C. Understanding and preventing drug interactions in elderly patients / J.C. Delafuente // Crit Rev Oncol Hematol. – 2003. – №48(2). – Р.133-143.
- Dunphy T.W. The pharmacist's role in the prevention of adverse drug interactions / T.W. Dunphy // Am J Hosp Pharm. – 1969. – №26(7). – Р. 366-377.
- Ejvinsson G. Effect of quinidine on plasma concentrations of digoxin / G. Ejvinsson // BMJ. – 1978. – №1. – Р. 279-280.
- Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review / A.X. Garg [et al.] // JAMA. – 2005. – №293(10). – Р. 1223-1238.
- Geppert U. Drug interactions in clinical practice. A pilot project for quality assurance in prescribing / U. Geppert, W. Beindl, T. Hawranek // Hautarzt. – 2003. – №54(1). – Р. 53-57.
- Hedman A. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine / A. Hedman, B. Angelin, A. Arvidsson // Clin Pharmacol Ther. – 1990. – №47. – Р. 20-26.
- Hohl C.M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department / C.M. Hohl, J. Dankoff, A. Colacone // Ann Emerg Med. – 2001. – №38(6). – Р. 666-671.
- Juurlink D.N. Drug-drug interactions among elderly patients hospitalized for drug toxicity / D.N. Juurlink, M Mamdani, A Kopp // JAMA. – 2003. – №289 (13). – Р. 1652-1658.
- McDonnell P.J. Hospital admissions resulting from preventable adverse drug reactions / P.J. McDonnell, M.R. Jacobs // The Annals of Pharmacotherapy. – 2002. – №36. – Р. 1331-1336.
- Salassa R.M. The effect of para-aminobenzoic acid on the metabolism and excretion of salicylate / R.M. Salassa, J.L. Bollman, T.J. Dry // J Lab Clin Med. – 1948. – 33(11). – Р. 1393-1401.
- Seymour R.M. Important drug-drug interactions in the elderly / R.M. Seymour, P.A. Routledge // Drugs Aging. – 1998. – №12. – Р. 485-494.
- Sjoqvist F. Historical perspectives: drug interactions – it all began with cheese / F. Sjoqvist, Y. Bottiger // J Intern Med. – 2010. – №268(6). – Р. 512-515.
- Sjoqvist F. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances / F. Sjoqvist // Proceedings of the Royal Society of Medicine. – 1965. – №58. – Р. 967-978.
- Stanton L.A. Drug-related admissions to an Australian hospital / L.A. Stanton, G.M. Peterson, R.H. Rumble // J Clin Pharm Ther. – 1994. – №19. – Р. 341-347.
- von Euler M. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization / M. von Euler, E. Eliasson, G. Ohlen // Pharmacoepidemiol and Drug Saf. – 2006. – №15(3). – Р. 179-184.
Supplementary files
